Background High-grade gliomas are the most common primary brain tumours.
Pseudoprogression describes the false appearance of radiation-induced progression on …

Malignant gliomas are the most frequently occurring, devastating primary brain tumors, and
are coupled with a poor survival rate. Despite the fact that complete neurosurgical resection …

Glioblastomas exhibit vast inter-and intra-tumoral heterogeneity, complicating the
development of effective therapeutic strategies. Current in vitro models are limited in …

Purpose: Novel agents are currently combined with radiation and temozolomide (RT+ TMZ)
in newly diagnosed glioblastoma using overall survival as the primary end point. Results of …

Blood tests to detect circulating tumor cells (CTC) offer great potential to monitor disease
status, gauge prognosis, and guide treatment decisions for patients with cancer. For patients …

Purpose To compare gadoteridol and ferumoxytol for measurement of relative cerebral
blood volume (rCBV) in patients with glioblastoma multiforme (GBM) who showed …

BACKGROUND: Convection-enhanced delivery of chemotherapeutics for the treatment of
malignant glioma is a technique that delivers drugs directly into a tumor and the surrounding …

Background Diagnosis of pseudoprogression in patients with glioblastoma multiforme
(GBM) is limited by Response Assessment in Neuro-Oncology (RANO) criteria to 3 months …

Over the last decade, pseudoprogression as a clinically significant entity affecting both
glioma patient management and the conduct of clinical trials has been recognized as a …

Abstract Recommendation 1: Multidisciplinary Approach: To optimize treatment outcomes,
the management of patients with recurrent glioblastoma should be individualized and …